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Aquatic vertebrate organisms such as zebrafish have been used for over a decade to
model different types of human cancer, including hematologic malignancies. However,
the introduction of gene editing techniques such as CRISPR/Cas9 and TALEN, have
now opened the road for other organisms featuring large externally developing embryos
that are easily accessible. Thanks to its unique diploid genome that shows a high degree
of synteny to the human, combined with its relatively short live cycle, Xenopus tropicalis
has now emerged as an additional powerful aquatic model for studying human disease
genes. Genome editing techniques are very simple and extremely efficient, permitting
the fast and cheap generation of genetic models for human disease. Mosaic disruption
of tumor suppressor genes allows the generation of highly penetrant and low latency
cancer models. While models for solid human tumors have been recently generated,
genetic models for hematologic malignancies are currently lacking for Xenopus. Here we
describe our experimental pipeline, based on mosaic genome editing by CRISPR/Cas9,
to generate innovative and high-performing leukemia models in X. tropicalis. These add
to the existing models in zebrafish and will extend the experimental platform available
in aquatic vertebrate organisms to contribute to the field of hematologic malignancies.
This will extend our knowledge in the etiology of this cancer and assist the identification
of molecular targets for therapeutic intervention.
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INTRODUCTION
Xenopus laevis and Xenopus tropicalis have been used extensively in developmental and cell biology,
biochemistry, functional genomics and immunology. Embryos develop externally and tadpoles are
transparent, features that facilitate experimental manipulation and post-factum analysis of animals
(Robert and Ohta, 2009; Banach and Robert, 2017). Interestingly, in contrast to X. laevis and
teleosts, X. tropicalis has a true diploid genome with high conservation of gene synteny with the
human genome (Hellsten et al., 2010), making it an attractive biomedical genetic model organism.
The immune system of Xenopus demonstrates striking similarities to that of mammals and a
considerable number of immunological studies have already been performed (Banach and Robert,
2017). Recent advances in genome editing technologies have now made it possible to efficiently
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disrupt gene function in Xenopus, reinforcing it as an organism
for modeling human disease, including the generation of solid
tumor models (Van Nieuwenhuysen et al., 2015; Naert et al.,
2016). Evidently, these genome editing strategies could also
be applied for detailed studies in immunology and especially
in generating models for hematologic malignancies. Here, we
elaborate on strategies to generate and analyze hematologic
malignancy models in X. tropicalis. We discuss how these
Xenopus models can be applied for identifying driver and
modifier genes and cancer dependency factors with possible
therapeutic potential.
THE IMMUNE SYSTEM OF XENOPUS
TROPICALIS
The innate immune system of Xenopus consists of the same
cell types as mammals and their primary function is to
eradicate infected cells. Neutrophils, basophils, eosinophils as
well as polymorphonuclear cells, macrophages dendritic cells and
lymphocytes have all been detected (Hadji-Azimi et al., 1987;
Robert and Ohta, 2009; Neely et al., 2018). Toll like receptor
(TLR) genes are present and execute the same role as their
mammalian counterparts in recognizing pathogen-associated
molecular patterns (PAMPs; Roach et al., 2005). Xenopus has NK
cells that eliminate virally infected and cancer cells by cytotoxic
activity (Horton et al., 2000; Horton et al., 2003). Furthermore,
innate immunity includes the three activation pathways of the
complement system (classical, alternative and lectin) as well as
antimicrobial peptides secreted by the epidermal layers (Zasloff,
2002).
Also the overall pattern and function of adaptive immunity
is conserved with mammals. Orthologs of all major mammalian
immune genes have been identified (Schwager et al., 1988,
1991; Chretien et al., 1997; Shi and Ishizuya-Oka, 1997; Flajnik,
2018). IgM is widely expressed and, similar to IgX (homolog of
mammalian IgA), its expression is not dependent on the thymus
(Tochinai, 1976). In contrast, expression of IgY (homolog of IgG
and IgE) is thymus dependent and is detected in the thymus,
spleen and peripheral blood (Mussmann et al., 1998). Next to
those three major Ig isotypes, IgD has been reported (Ohta et al.,
2006; Flajnik, 2018). Accessory molecules like the B7 family (and
B7 receptor) (Hansen et al., 2009), cytokines like the TNFSF
family (and TNFSF receptor) (Bernard et al., 2007), IFN gamma
and the interleukins IL-2, -6, -7, -17, -21 and -23 have all been
identified (Qi and Nie, 2008). B cell receptors (BCR) recognize
specific epitopes on foreign antigens and T-cell receptors (TCRs)
recognize short peptides presented by MHC class I and II. CD4
and CD8 T cells recognize and bind to MHC class II and MHC
class I epitopes, respectively. Naive T cells demand an extra
stimulatory signal (by costimulatory molecules B7 and CD40) to
execute an immunological response. Activated T cells propagate
and differentiate into cytotoxic T lymphocytes and CD4 T helper
cells. The latter release cytokines that act either on CD8 T
cells and B cells, or directly on pathogens. After immunological
response, the majority of T cells die through apoptosis, except for
T memory cells, which orchestrate secondary immune responses.
Despite the similarities to mammals, there are some
fundamental developmental differences that confer special
features to the Xenopus immune system. (1) The fetal liver is
the main site for hematopoiesis, unlike the bone marrow (BM)
in mammals (Ciau-Uitz et al., 2014). In adult Xenopus, the BM
functions as a reservoir pool (Robert and Ohta, 2009), while
no BM is present in tadpoles (Du Pasquier et al., 2000). (2)
Lymph nodes are absent in Xenopus, and the spleen functions
as a major secondary lymphoid organ, which interestingly is
deprived of germinal centers (GCs; Du Pasquier and Schwager,
1991; Du Pasquier et al., 2000; Neely et al., 2018). Xenopus
also lack follicular dendritic cells but their function in the
spleen is taken over by “double-duty” antigen presenting cells
(Neely et al., 2018). (3) During metamorphosis, the thymus
undergoes histolysis and 50–90% of thymic lymphocytes die (Du
Pasquier and Weiss, 1973; Du Pasquier et al., 1989). The thymic
remnants shift toward the tympanum and tissue is regenerated
simultaneously with a second wave of lymphoid stem cells
colonizing the renewed thymus (Bechtold et al., 1992; Robert and
Ohta, 2009). Premature B cells diminish during metamorphosis
and regenerate in the liver at Nieuwkoop stage 60. In adult life,
the major site of B cell differentiation shifts from the liver to the
spleen (Hadji-Azimi et al., 1987). The larval type BCR repertoire
is less variable compared to the adult. This could be explained by
deficiency of N-nucleotide diversity during BCR rearrangement
(Du Pasquier et al., 2000). However, VH diversity is similar
between larvae and adults (Du Pasquier et al., 2000). Even though
the Xenopus spleen has no GCs, somatic hypermutation occurs
in adults and larvae. As in mammals, αβ T cell differentiation is
thymus dependent (Robert and Ohta, 2009). Little information
is available regarding the TCR repertoire. However, the TCR
gene rearrangements (both larvae and adult stage) exhibit many
similarities to mammals (Robert et al., 2001).
Because of its unique and conserved features, Xenopus
provided important insights concerning regulation of MHC
expression and immunotolerance. MHC class expression differs
between larvae and adult and thus affects differently the tolerance
toward skin grafts (Du Pasquier and Flajnik, 1990; Rollins-Smith
et al., 1997). Moreover, Xenopus is a reliable system for immune-
cancer studies. Xenopus can develop lymphoid tumors from
which cell lines have been derived (Du Pasquier and Robert, 1992;
Robert et al., 1994). These cell lines have been obtained from
different strains and exhibited differential tumorigenicity, which
was attributed to divergent expression of MHC Ia and MHC Ib
genes (Goyos et al., 2007).
HEMATOLOGIC MALIGNANCIES
Leukemia is among the leading cancers worldwide (Bray et al.,
2018). In adult patients, the most frequent types are acute myeloid
leukemia (AML) and chronic myeloid leukemia (CML). Acute
lymphoblastic leukemia (ALL), a malignant transformation and
propagation of lymphoid progenitor cells in the BM, peripheral
blood and various extramedullary sites, affects both adults
and children (Van Vlierberghe and Ferrando, 2012; Terwilliger
and Abdul-Hay, 2017). Most incidences of ALL are derived
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from the B cell lineage (B-ALL) while 25% of adult ALL and
15% of pediatric ALLs originate in the T cell lineage (T-ALL;
You et al., 2015). B-ALL involves characteristic chromosomal
translocations such as t(12;21) [ETV6-RUNX1], t(1;19) [TCF3-
PBX1], t(9;22) [BCR-ABL1] and rearrangements of the MLL
locus (Woo et al., 2014). T-ALL most frequent mutational
events include activation of the Notch pathway, deregulation
of cell cycle regulators and mutations in chromatin remodeling
complexes (Van Vlierberghe and Ferrando, 2012). Although
prognosis for B-ALL and T-ALL in general is good, still
15–20% of patients experience disease relapse (Cooper and
Brown, 2015; You et al., 2015). In addition, patients often
experience severe therapy related toxicities (Van Vlierberghe
and Ferrando, 2012). Thus, identification of more effective and
less toxic therapies is important. More effective therapies are
also required for AML, where older patients, and those who
exhibit relapsed disease, demonstrate poor prognosis (Dombret
and Gardin, 2016). For CML patients treated with targeted
therapies, like tyrosine kinase inhibitors, prognosis is significantly
improved (Jabbour and Kantarjian, 2018). Animal models
have already contributed majorly to leukemia research and
have expanded the molecular biomedical knowledge, allowing




The majority of mouse ALL models have been generated
by transgenic strategies or by cells transduced retrovirally to
express mutant proteins or genomic aberrations (chromosomal
translocations, activating and inactivating mutations) associated
with ALL (Gutierrez et al., 2014; Jacoby et al., 2014; Kohnken
et al., 2017). In addition, xenografts models of human
ALL samples engrafted in immunocompromised mice have
also been generated. Xenografts models enlighten topics
that were previously difficult to address concerning ALL
microenvironment, leukemic stem cells, prognostic markers and
new therapeutic agents (Gopalakrishnapillai et al., 2016). The
last decade has also seen the emergence of leukemia models in
zebrafish, mostly mediated by mosaic transgenic expression of
oncogenes such as MYC in the lymphocytic lineage. However,
details regarding the established murine and zebrafish ALL
models go beyond the scope of this perspective.
As mentioned before, the recent progress in genome editing
technologies has created a true revolution in generating models
for human disease. This also applies to X. tropicalis, which unlike
zebrafish (Taylor et al., 2001; Howe et al., 2013) favorably has
a true diploid genome (Naert et al., 2017). Evidently, homology
between human and mice is greater compared to X. tropicalis.
Nevertheless, signaling pathways that are involved in TCR and
BCR formation as well as immune system cell types are highly
conserved (Robert and Ohta, 2009). Therefore, X. tropicalis is
suitable for modeling hematologic diseases. Targeting of tumor
suppressor genes (TSGs) by CRISPR/Cas9 (or TALENs) results in
F0 mosaic mutants, commonly mentioned as crispants. In these
crispants, the cell clones that acquired bi-allelic loss of function
(LOF) of the TSG may be able to form tumors.
Our lab published two genetically engineered tumor models
in X. tropicalis (Naert et al., 2017). In both cases, solid tumors
were obtained (e.g., desmoid tumors and retinoblastoma) and
histological and immuno-histochemical evaluation, as well as
genotyping, was straightforward and further confirmed these
tumors to closely resemble their human counterparts (Naert
et al., 2017). Recently, we also generated leukemia models in
Xenopus by inducing LOF mutations in TSGs that are frequently
mutated in T-ALL. While genotypic and phenotypic analysis of
solid tumor models in X. tropicalis is straightforward, this is
not the case for hematologic malignancies. In mice and humans,
characterization of hematologic malignancies relies primarily on
immunophenotyping with sets of antibodies recognizing specific
surface markers on the transformed leukocytes. Unfortunately,
such antibodies are largely lacking for Xenopus. Therefore, we
designed and applied alternative strategies inspired by those
used to analyze solid tumors. Our strategies, encompass both
phenotypic and genotypic analysis of F0 mosaic mutants that are
symptomatic leukemic (Figure 1).
Phenotypic Analysis of F0 Crispants
Embryos are injected in the blastomeres that contribute to
the definitive blood and animals are raised until they present
symptoms of leukemic disease such as abnormal swimming
behavior, lethargy, pallor and hemorrhagic spots. Animals with
these symptoms are sedated and whole blood is withdrawn from
the heart by glass capillaries. Identification of leukocytes in the
blood is complicated by the fact that amphibians, like fish, birds
and reptiles, have nucleated erythrocytes (Maxham et al., 2016).
Unfortunately, red blood cell lysis buffer, usually applied to lyse
erythrocytes and facilitate leukocytes isolation, cannot be used.
Hence, blood from tadpoles is processed either by manual cell
count in a hemocytometer or by flow cytometry.
Analyzing the Blood (Figure 1)
A first indication for leukemia may be abnormal hematocrit
levels. However, this analysis is not possible for tadpoles and
young froglets since it requires larger amounts of blood (∼50 µl).
For manual cell counting, whole blood is diluted in Natt-
Herrick solution (Maxham et al., 2016). By using a common
hemocytometer, single blood cells are counted and categorized
as white blood cells (WBCs), red blood cells (RBCs) or platelets,
to calculate the WBC/RBC ratio. Natt-Herrick staining allows
discrimination between myeloid derivatives and lymphocytes.
Wright-Giemsa staining of a blood smear can also be used as
an alternative way to identify overrepresentation of lymphoblast-
like cells. In our experience, analysis of blood smears can be
complicated by partially lysed erythrocytes.
Compared to manual cell counting, flow cytometric analysis is
more quantitative, especially if the blood sample can be stained
for lymphocyte markers. Even though the markers available for
Xenopus are very limited, we are still able to define whether the
leukemia has a T cell or B cell origin. For now, no good myeloid
markers are available. For larval stage blood (or for metamorphic
stages) we suggest staining for CD8 and CD3. Both are used
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FIGURE 1 | (A) Overview illustrating the experimental approaches to document the development of hematologic malignancies. (A) Scheme documenting the
different types of analysis performed to investigate the presence of hematologic malignancies. Genotyping is performed on the blood and the dissected thymus by
PCR amplification of the CRISPR/Cas9 targeted regions followed by deep sequencing of the PCR fragments and analysis of the INDEL signatures (left). Phenotyping
is done by manual counting of the blood cells or by flow cytometry. In addition, lymphoid organs such as the thymus, and spleen are subjected to
immunohistological analysis and transcriptomic profiling. Other organs like the kidneys and the liver are evaluated for the presence of proliferating and disseminating
lymphoblasts (right). (B) Timing of the analyses that can be performed for assessing the presence of leukemic disease and to evaluate disease progression. Legend:
“++,” “+” and “–” refer to straightforward, difficult and impossible to nearly impossible to perform, respectively. Analysis can be impossible to do due to (a) immature
cells jeopardizing cell discrimination, (b) too low input of thymocytes for flow cytometry in early stage tadpoles, (c) shrinking of thymi in older animals, which impedes
successful dissection, (d) aberrant scattering in immature cells, (e) extremely small size of the spleen in early stage tadpoles, which therefore is difficult to dissect.
Drawings adopted from Xenbase (http://www.xenbase.org/anatomy/alldev.do).
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as T cell specific surface markers. However, cytoplasmic CD3,
detected upon cell permeabilization, is a marker of immature
lymphoblast, which are clonally expanded in T-ALL (Robert and
Ohta, 2009; Van Vlierberghe and Ferrando, 2012). Furthermore,
larval and post-metamorphosis stage blood can be stained for
MHC class II and cytoplasmic IgM, markers for B cells (Loftin
et al., 1985). Next to these early lymphocyte markers, IgY staining
can be included for identifying more mature B cells (Robert
and Ohta, 2009). While the current lymphocyte surface and
cytoplasmic markers allow us to discriminate between T- and
B-ALL, they do not allow to define the different ALL subtypes. Of
note, a recent report describes the use of acridine orange staining
to discriminate different blood cell types by flow cytometry in
Xenopus (Sato et al., 2018).
Analogs to zebrafish, a transgenic rag2:EGFP line in X.
tropicalis can reinforce and facilitate phenotypic analysis
of leukemic animals. Since rag2 guides development and
maturation of both T and B cells (Langenau et al., 2003),
both cell populations will be GFP positive in these transgenic
animals. Performing CRISPR/Cas9 injections in this transgenic
line to generate ALL F0 mosaic crispants, will offer unique
opportunities. Firstly, due to the transparency of larval stages,
circulating and infiltrating lymphoblasts can be detected.
Secondly, GFP positive lymphocytes/lymphoblasts can be
easily separated by flow cytometry. This obviates the need
for lymphocyte markers. Thirdly, sorted lymphoblasts can be
transplanted into immunocompromised animals to evaluate the
tumorigenic potential of these leukemic cells/blasts. Importantly,
all aforementioned applications have already been used
successfully in zebrafish (Langenau et al., 2003, 2005). In our lab,
we have established a rag2:EGFP F0 line and a rag2+/− lines for
these experiments. These tools will strengthen the validity of our
model and facilitate future applications, especially for compound
screening.
Analyzing Internal Lymphoid Organs (Figure 1)
Next to the blood, also the analysis of the lymphoid organs
like the thymus, spleen and liver can be informative regarding
leukemia establishment and progression. Healthy spleens,
contain white and red pulp, that are well delineated by a boundary
layer (Manning, 1991; Lametschwandtner et al., 2016). The red
pulp establishes a network of reticular cells, which accommodate
blood vessels and sinuses, and a perifollicular area of lymphocytes
around the white pulp (Lametschwandtner et al., 2016). The
murine spleen in ALL demonstrates disturbed architecture and
especially in T-ALL, white pulp overrules the red pulp and
GC organization is compromised (Chen et al., 2015). Even
though the Xenopus spleen lacks GCs, in leukemic animals
tissue architecture is disorganized. CD3 immuno-histochemical
staining in tissue sections of spleen is informative to determine
abnormalities in the organization of the T cell and B cell zones.
Interestingly in thymic sections of leukemic animals in Xenopus,
the medulla of the thymus invades the cortex and disturbs the
architecture of these tissues. This abnormality is obvious in
both H&E staining as well as in CD3 stained thymi sections.
Furthermore, in murine ALL models, infiltration of liver, spleen
and kidneys by lymphoblasts is observed (Jacoby et al., 2014;
Pan et al., 2018). Similarly, CD3 immuno-histochemical staining
of Xenopus liver and kidney tissue sections can easily assess
lymphoblasts infiltration. Alternatively, cell suspensions derived
from lymphoid organs can be examined for distribution of the
same lymphocyte markers that are used in whole blood flow
cytometric analysis.
Genotypic Analysis of F0 Crispants
(Figure 1)
Leukemia is a disease of the hematologic system that results in
clonal expansion of malignant lymphoblasts. Depending on the
stage of oncogenic transformation, the clone of malignant cells
can show a uniform rearrangement of their BCR (B-ALL) or
TCR (T-ALL; Schultz and Farkas, 1993). This genomic BCR/TCR
rearrangement can be used as a signature to identify an expanded
malignant clone and can be detected by Southern Blot analysis
(Schultz and Farkas, 1993) or by Rapid Amplification of cDNA
Ends (RACE; Rosati et al., 2017). We apply alternative methods
exploiting the specifics of the genome editing techniques. Mosaic
mutant animals generated by CRISPR/Cas9, that bear frame
shifting LOF mutations in TSGs have unique genomic features.
When Cas9 creates double strand breaks (DSBs) in targeted
DNA sequences, the majority of DSBs is repaired by Non-
Homologs End Joining (NHEJ). NHEJ repairs the DSBs by
incorporating or omitting random nucleotides (Zhang et al.,
2014; Wang et al., 2016). As a result, variable patterns of
insertions/deletions (INDELS) are generated in the cells of the
F0 crispants (Naert et al., 2017). However, the leukemic cells
of a F0 crispant will present with clear enrichment for limited
INDEL patterns. Therefore, an effective way to evaluate clonal
lymphoblasts expansion is to subject the PCR amplicon of the
CRISPR targeted region to Next Generation Sequencing (NGS)
(Figure 1). For T-ALL, thymi, which are the main localization
site for the T cell lymphoblasts, are dissected from F0 crispants
and genomic DNA is extracted. The area of interest (i.e., the
target site of the sgRNA) in the CRISPR/Cas9 targeted gene(s),
is PCR amplified, bar-coded and included in a NGS run. INDEL
patterns can subsequently be detected by BATCH-GE analysis





Some complications and challenges for modeling hematologic
malignancies still remain. X. tropicalis has a small size compared
to X. laevis. Cardiac puncture in tadpoles with glass capillary
needles is challenging and only small amounts of blood
can be collected. Larval blood cells are also very fragile
compared to adult blood. The small blood volumes restrict
subsequent phenotypic analysis, especially flow cytometry.
Detailed immunophenotyping of the blood from a symptomatic
animal is not possible. However, these complications could be
partially bypassed by using transgenic lines such as rag2:EGFP.
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FIGURE 2 | Experimental set-up for the identification of driver mutations in tumor suppressor genes (TSG) and for dependency factors. (A) Injection of Cas9
recombinant proteins and guide RNAs targeting putative TSGs created mosaic mutant animals (crispants) that contain cells with mono-allelic or bi-allelic inactivation
of the driver genes. Cells with bi-allelic inactivation will have a proliferative advantages over the wild type (WT) or mono-allelic mutant cells. When disease is
observed, DNA is extracted from the thymus and after PCR amplification of the targeted regions, the PCR amplicon is subjected to deep sequencing. The presence
of two unique frame shifting INDELs at equal proportion is indicative of a clonally expanding subpopulation, characteristic for leukemic disease. (B) Multiplexing of
guide RNAs targeting a known driver gene together with a candidate dependency factor gene. If the candidate is not a dependency factor, clonal expanding cells will
be present – identified by the INDEL signature of the driver gene (orange) – with bi-allelic inactivation of the analyzed gene (green) (top). However, in case of a
genuine dependency factor gene (purple), expanding clones will never contain bi-allelic inactivation of this gene (bottom).
Indeed, the rag2:EGFP line in zebrafish has greatly facilitated the
analysis of the leukemic models in this organisms. This transgenic
line allows to gate out lymphocytes from other blood cell types
and thus reduces the number of cell markers to be used. In
addition, it allows for in vivo detection of leukemic animals,
facilitates follow up of disease progression, and provides the




In addition to current cancer models, X. tropicalis could expand
the toolbox of model systems for detailed in vivo characterization
and identification of novel therapeutic strategies. It shares with
zebrafish the external development and the associated ease with
which to generate mosaic or full knockout models, but has the
unique property of a true diploid genome. In addition, although
it still lacks some typical secondary lymphoid organs found in
mammals, like lymph nodes and GCs, other features such as a
clear separation of the red pulp and white pulp in the spleen
and canonical class switch recombination of immunoglobulin
receptors are still absent in teleosts (Neely et al., 2018). Exploiting
the easy and efficient CRISPR/Cas9 mediated multiplexed
genome editing and positive clonal selection of leukemic cells will
allow the identification of novel driver and modifier mutations
(Figure 2A). Alternatively, an existing crispant Xenopus leukemic
model can be exploited for screening of genes that are essential
for proliferation and/or viability of the leukemic cells, the so-
called dependency factors (McDonald et al., 2017) (Figure 2B).
This application is well established in our lab for solid tumor
models (Naert et al., unpublished). This efficient pipeline could
be transferred to our ALL model by disrupting the gene of
interest with CRISPR/Cas9. Since dependency factor expression
is under positive selection, there will be selective pressure
to maintain at least one functional allele in the expanding
leukemic clones. Besides identifying new target genes for
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therapies, our model can also be used for compound screening.
We have already successfully treated F0 crispants exhibiting
solid tumors with candidate compounds. The experimental
approach was straightforward since compounds could be easily
taken up by the animal via the water by several routes
(gills, skin, water uptake) or alternatively by intraperitoneal
injection. The administration route is determined by the
(water) solubility and the price of the compound. Poorly
soluble or very expensive compounds are preferentially injected
intraperitoneally. Evidently, a critical point is the amount of
compound to be administered to the animals. For injections, we
rely on the concentrations and injection schemes described for
the compound in mouse studies. For administration via the water,
we base the concentrations on cell culture studies. Toxicity can
first be tested on early pre-feeding tadpoles. We usually start with
a five-fold concentration of the IC50 value. Ideally a biological
response (e.g., modification of a protein substrate or expression
of a known target gene) is used as a readout for effectiveness of the
compound (e.g., in lysed liver extracts). Evidently it is important
to obtain ethical approval for these treatments.
The previously mentioned use of rag2 knockout lines for
cancer cell grafting may ultimately be not straightforward.
Evidently, these animals still have an innate immune system
where for instance natural killer cells could still affect the
transplanted cells. Also, these animals may be prone to disease.
Therefore, an interesting future direction will be the use of
X. tropicalis inbred strains. This will be a great tool for grafting
of cancer cells directly from a diseased donor or from cell lines
established derived from these strains. Several inbred strains
are currently available from the National BioResource Project
(NBRP), the Japanese X. tropicalis stock center1.
1 http://nbrp-xt.hiroshima-u.ac.jp/xenobiores_en/iweb_en/Top.html
In sum, X. tropicalis is an emerging organism for modeling
hematologic malignancies. With some investment, this aquatic
vertebrate could become a strong tool for laboratories that are
active in identifying new molecular targets for therapy as well as
new driver mutations in hematological malignancies.
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